权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD)

心血管疾病素养低下的药剂师干预 (PILL-CVD)

基本信息

批准号：
7303342
负责人：
SUNIL KRIPALANI
金额：
$ 49.45万
依托单位：
VANDERBILT UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
起止时间：
2007-09-01 至 2010-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7303342
关键词：
Academic Medical Centers Acute Adherence Adverse effects Adverse event Area Attention Blinded Cardiovascular Diseases Cardiovascular system Caring Cessation of life Communication Condition Counseling Diabetes Mellitus Effectiveness Effectiveness of Interventions Evaluation Event Funding Hand Health Status Heart failure Home environment Hospitalization Hospitals Hypertension Incidence Inpatients Institute of Medicine (U.S.)Institution Instruction Intervention Investigation Knowledge Medication Errors Medicine Morbidity - disease rate Myocardial Infarction Nurses Outcome Patient Discharge Patient Education Patients Pharmaceutical Preparations Pharmacists Physicians Provider Publishing Qualitative Research Randomized Randomized Controlled Trials Rate Reporting Research Research Personnel Safety Services Severities Subgroup Teaching Hospitals Telephone Time Treatment Protocols Universities Upper arm Woman acute coronary syndrome adjudication base cost day design disorder control experience follow-up health literacy hospital readmission hypercholesterolemia improved inner city literacy mortality patient oriented pill prevent programs skills tertiary care therapy design tool

项目摘要

DESCRIPTION (provided by applicant): Serious medication errors are common after hospital discharge and cause significant patient morbidity. Errors are more common among patients taking cardiovascular medications and may also be more common among patients with low health literacy. On the other hand, patients with low health literacy may benefit more than other patients from interventions designed to improve knowledge and skills. The objective of this research is to reduce the incidence of serious medication errors during the first 30 days after hospital discharge among patients hospitalized with acute coronary syndromes (ACS) or heart failure (HF) exacerbation. We will conduct a randomized controlled trial of a literacy-sensitive, pharmacist-based intervention in 862 patients discharged from the general medicine service at two academic medical centers: Emory University/Grady Memorial Hospital (GMH) and Brigham and Women's Hospital (BWH). The study will have two arms: 1) Usual Care: pharmacists performing only routine evaluations of medication orders, physicians performing medication reconciliation, and nurses providing medication counseling at discharge; and 2) Intervention: pharmacist assistance with medication reconciliation, pharmacist counseling of patients at the time of discharge, provision of a literacy-sensitive patient education tool detailing the discharge medications, and a follow-up phone call 1-2 days later and subsequently if needed. Randomization will occur at the level of the patient. The primary outcome will be the percent of patients with at least one serious medication error within 30 days after hospital discharge. Serious medication errors consist of: 1) actual adverse drug events (ADEs) that could have been prevented (preventable ADEs), 2) actual ADEs that could have been reduced in severity or duration (ameliorable ADEs), and 3) medication discrepancies or non- adherence with the potential to cause adverse events (potential ADEs). Adjudication of serious medication errors will be performed by two independent physicians blinded to study assignment. Subgroup analyses will be performed by level of health literacy to determine if patients with inadequate health literacy are more likely to benefit from the intervention. Program costs will also be assessed. If successful, this intervention could offer an important means of reducing medication errors in the post-hospitalization period.

描述（由申请人提供）：严重用药错误在出院后很常见，并导致患者严重发病。错误在服用心血管药物的患者中更常见，在健康素养低的患者中也可能更常见。另一方面，健康素养低的患者可能比其他患者从旨在提高知识和技能的干预措施中受益更多。本研究的目的是降低急性冠脉综合征（ACS）或心力衰竭（HF）加重住院患者出院后前30天内严重用药错误的发生率。我们将在两个学术医疗中心（埃默里大学/格雷迪纪念医院（GMH）和布里格姆妇女医院（BWH））的862名普通医学服务出院的患者中进行一项识字敏感，基于药剂师的干预的随机对照试验。本研究将分为两组：1）家庭护理：药剂师仅对医嘱进行常规评估，医生进行药物核对，护士在出院时提供药物咨询; 2）干预：药剂师协助进行药物核对，出院时药剂师对患者进行咨询，提供详细说明出院药物的识字敏感的患者教育工具，并在1-2天后以及随后（如果需要）进行电话随访。随机化将在患者水平进行。主要结果将是出院后30天内至少发生一次严重用药错误的患者百分比。严重用药错误包括：1）本可预防的实际药物不良事件（ADE）（可预防的ADE），2）严重程度或持续时间本可降低的实际ADE（可改善的ADE），以及3）可能导致不良事件的用药差异或不依从（潜在ADE）。严重用药错误的裁定将由两名对研究分配不知情的独立医生进行。将按健康素养水平进行亚组分析，以确定健康素养不足的患者是否更有可能从干预中受益。还将评估方案成本。如果成功，这种干预可以提供一个重要的手段，减少住院后时期的用药错误。